Access Bio, Inc.
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
950130 | KO
Overview
Corporate Details
- ISIN(s):
- KR8840090003
- LEI:
- Country:
- United States of America
- Address:
- 65 Clyde Road Suite A, Somerset NJ
- Website:
- https://accessbio.net/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Access Bio, Inc. is a biotechnology company dedicated to the prevention and early diagnosis of infectious diseases. It engages in the research, development, manufacturing, and marketing of in vitro rapid diagnostic tests (IVD), biosensors, and molecular diagnostic products. The company is a key partner in global health, recognized for its comprehensive portfolio of tests for diseases such as malaria, HIV, HPV, and COVID-19. Through its products, including the CareStart™ line, Access Bio focuses on providing high-quality, accessible diagnostic solutions to combat serious health threats worldwide, particularly in developing nations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-01-31 00:00 |
현금ㆍ현물배당결정
|
Korean | 12.1 KB | ||
| 2022-12-23 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 16.9 KB | ||
| 2022-12-14 00:00 |
기타경영사항(자율공시)(제21기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)
|
Korean | 4.7 KB | ||
| 2022-12-12 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득(제5회차)
|
Korean | 10.3 KB | ||
| 2022-11-23 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 10.1 KB | ||
| 2022-11-17 00:00 |
기타경영사항(자율공시)(KDR 배당을 위한 투자자 유의사항(QI 자격을 취득한 계좌관리기관의 명단))
|
Korean | 9.1 KB | ||
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | 1.3 MB | ||
| 2022-11-01 00:00 |
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
|
Korean | 6.0 KB | ||
| 2022-11-01 00:00 |
수시공시의무관련사항(공정공시)(2022 사업연도 결산 이익배당 실시 계획)
|
Korean | 17.8 KB | ||
| 2022-10-11 00:00 |
전환가액의조정(제5회차)
|
Korean | 10.8 KB | ||
| 2022-09-13 00:00 |
전환가액의조정(제5회차)
|
Korean | 10.4 KB | ||
| 2022-08-16 00:00 |
반기보고서 (2022.06)
|
Korean | 1.2 MB | ||
| 2022-06-27 00:00 |
신탁계약에의한취득상황보고서
|
Korean | 43.8 KB | ||
| 2022-05-23 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2022-05-16 00:00 |
분기보고서 (2022.03)
|
Korean | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all Access Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Access Bio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Access Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
